US Patent Issued to Numab Therapeutics on Sept. 1 for "Antibody specifically binding to human serum albumin" (Swiss, French Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,101, issued on Sept. 1, was assigned to Numab Therapeutics AG (Horgen, Switzerland).

"Antibody specifically binding to human serum albumin" was invented by David Urech (Jona, Switzerland), Christian Hess (Zurich), Alexandre Simonin (Rosenau, France) and Stefan Warmuth (Au, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a multispecific antibody comprising at least one domain specifically binding to a tumor-associated immune checkpoint antigen with low affinity, and at least one domain specifically binding to a tumor-associated antigen (TAA), and pharmaceutical compositions and methods of use thereof. The p...